Explore the words cloud of the PRINT-AID project. It provides you a very rough idea of what is the project "PRINT-AID" about.
The following table provides information about the project.
|Coordinator Country||Finland [FI]|
|Total cost||2˙265˙900 €|
|EC max contribution||2˙265˙900 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2017-01-01 to 2020-12-31|
Take a look of project's partnership.
|1||HELSINGIN YLIOPISTO||FI (HELSINGIN YLIOPISTO)||coordinator||538˙290.00|
|2||APTUIT (VERONA) SRL||IT (VERONA)||participant||258˙061.00|
|3||Academisch Medisch Centrum bij de Universiteit van Amsterdam||NL (AMSTERDAM)||participant||255˙374.00|
|4||UNIVERSITEIT ANTWERPEN||BE (ANTWERPEN)||participant||250˙560.00|
|5||UNIVERSITEIT GENT||BE (GENT)||participant||250˙560.00|
|6||VOXDALE BVBA||BE (WIJNEGEM)||participant||250˙560.00|
|7||UNIVERSIDADE DO PORTO||PT (PORTO)||participant||238˙356.00|
|8||POLITECHNIKA WARSZAWSKA||PL (WARSZAWA)||participant||224˙137.00|
|9||3DTECH OY||FI (SALO)||partner||0.00|
|10||BioSurface Technologies Corporation||US (Bozeman)||partner||0.00|
|11||MADAM THERAPEUTICS BV||NL (ZEVENHOVE)||partner||0.00|
|12||Montana State University Bozeman||US (Bozeman)||partner||0.00|
According to ECDC, over 4 million healthcare-associated infections in the EU cause 37,000 deaths and cost EUR 7 billion/year. Half of them are related to medical devices (i.e., catheters, implants) and 80% of these are related to bacterial biofilms. A recent EC report highlighted the medical device sector’s role in driving EU economic growth, employing 500k people in 25k companies (80% are SMEs) with annual sales of EUR 85 billion. The strategy to prevent medical device-infections is alteration of the device’s surface with antimicrobials. However, current antimicrobial surfaces don’t control bacterial growth in tissue surrounding implants, and only Sterilex® has received regulatory approval in the US as anti-biofilm agent. Participants in this proposal have earlier demonstrated a dramatic in vitro inhibition of biofilm formation by 3D-printing surfaces with antibiotics incorporated into the carrier polymers. This discovery opens new possibilities for printed medical devices that better resist biofilms. Our objective is to set-up a new European education platform to guide and inspire young researchers in the intersectoral exploration of innovative routes to counteract microbial biofilms by fabricating anti-infective, tailored, 3D-printed medical devices. Current opportunities for young researchers to receive an structured, inter-sectoral and up-to-date education on personalized medicine and medical devices are marginal, and to our knowledge PRINT-AID is the first ETN set up for this purpose. State-of-the-art printing technologies will be combined with in vitro and in vivo biofilm models and novel tools for data integration/standardization. Doctoral training will be performed within a high-quality network of 12 participants (5 industrial) from the EU and US. It will include online and face-to-face courses taught by researchers with academic and industrial expertise in biofilms, 3D-printing research, antimicrobials, material science, and drug development.
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRINT-AID" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PRINT-AID" are provided by the European Opendata Portal: CORDIS opendata.